210 related articles for article (PubMed ID: 24125987)
21. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory.
Bouchet S; Titier K; Moore N; Lassalle R; Ambrosino B; Poulette S; Schuld P; Belanger C; Mahon FX; Molimard M
Fundam Clin Pharmacol; 2013 Dec; 27(6):690-7. PubMed ID: 23113675
[TBL] [Abstract][Full Text] [Related]
23. Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?
Qin YZ; Jiang Q; Jiang H; Li JL; Li LD; Zhu HH; Lai YY; Lu XJ; Liu YR; Jiang B; Huang XJ
Leuk Res; 2013 Sep; 37(9):1035-40. PubMed ID: 23810191
[TBL] [Abstract][Full Text] [Related]
24. New tyrosine kinase inhibitors in chronic myeloid leukemia.
Martinelli G; Soverini S; Rosti G; Cilloni D; Baccarani M
Haematologica; 2005 Apr; 90(4):534-41. PubMed ID: 15820950
[TBL] [Abstract][Full Text] [Related]
25. Generics in chronic myeloid leukemia: current arguments for and against and the established evidence.
Soysal T; Eskazan AE; Ar MC
Expert Rev Hematol; 2014 Dec; 7(6):697-9. PubMed ID: 25292262
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
[TBL] [Abstract][Full Text] [Related]
27. The safety profile of imatinib in CML and GIST: long-term considerations.
Thanopoulou E; Judson I
Arch Toxicol; 2012 Jan; 86(1):1-12. PubMed ID: 21717109
[TBL] [Abstract][Full Text] [Related]
28. Imatinib mesylate for the treatment of chronic myeloid leukemia.
Soverini S; Martinelli G; Iacobucci I; Baccarani M
Expert Rev Anticancer Ther; 2008 Jun; 8(6):853-64. PubMed ID: 18533795
[TBL] [Abstract][Full Text] [Related]
29. Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome.
Xu XH; Huang LS; Yang J; Yu T; Tong JF; Yuan XG; Zhao XY
Leuk Lymphoma; 2013 Jan; 54(1):195-7. PubMed ID: 22574970
[No Abstract] [Full Text] [Related]
30. Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib.
Legros L; Guilhot J; Huault S; Mahon FX; Preudhomme C; Guilhot F; Hueber AO;
Leuk Res; 2014 Jun; 38(6):662-5. PubMed ID: 24553365
[TBL] [Abstract][Full Text] [Related]
31. Dose escalation of imatinib in chronic-phase chronic myeloid leukemia patients: is it still reasonable?
Rudzki J; Wolf D
Expert Rev Hematol; 2011 Apr; 4(2):153-9. PubMed ID: 21495925
[TBL] [Abstract][Full Text] [Related]
32. The challenge of the 'C' in CML.
Mauro MJ
Leuk Res; 2014 Mar; 38(3):286. PubMed ID: 24439564
[No Abstract] [Full Text] [Related]
33. [Chronic myeloid leukemia maintained major molecular response with intermittent dosage of imatinib mesylate].
Miyashita K; Fujimaki K; Ishigatsubo Y
Gan To Kagaku Ryoho; 2013 Mar; 40(3):405-7. PubMed ID: 23507609
[TBL] [Abstract][Full Text] [Related]
34. Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib.
Breccia M; Salaroli A; Serrao A; Zacheo I; Saracino R; Alimena G
Leuk Lymphoma; 2014 Jan; 55(1):204-6. PubMed ID: 23586870
[No Abstract] [Full Text] [Related]
35. EUTOS score predicts early optimal response to imatinib according to the revised 2013 ELN recommendations.
Bonifacio M; Binotto G; Calistri E; Maino E; Tiribelli M;
Ann Hematol; 2014 Jan; 93(1):163-4. PubMed ID: 24292539
[No Abstract] [Full Text] [Related]
36. VEGF in chronic myeloid leukemia treated with interferon and imatinib.
Aguayo A
Leuk Res; 2014 Jun; 38(6):660-1. PubMed ID: 24726782
[No Abstract] [Full Text] [Related]
37. CML: imatinib mesylate (Glivec) or something else?
Ghosh A
Nepal Med Coll J; 2007 Dec; 9(4):292. PubMed ID: 18298026
[No Abstract] [Full Text] [Related]
38. Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester.
Suppiah R; Kalaycio M
Leuk Lymphoma; 2006 Jun; 47(6):1149-50. PubMed ID: 16840209
[No Abstract] [Full Text] [Related]
39. Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
Yilmaz M; Demirhan O; Kuçukosmanoglu E; Pehlivan M; Okan V; Balat O; Pehlivan S
Leuk Lymphoma; 2007 Dec; 48(12):2454-6. PubMed ID: 18067024
[No Abstract] [Full Text] [Related]
40. Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia.
Michor F
Trends Pharmacol Sci; 2007 May; 28(5):197-9. PubMed ID: 17412430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
